Topiroxostat (Standard)
Topiroxostat (Standard) is the analytical standard of Topiroxostat. This product is intended for research and analytical applications. Topiroxostat (FYX-051) is a potent and orally active xanthine oxidoreductase (XOR) inhibitor with an IC50 value of 5.3 nM and a Ki value of 5.7 nM. Topiroxostat exhibits weak CYP3A4-inhibitory activity (18.6%). Topiroxostat has the potential for hyperuricemia treatment.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 98%
- CAS No.: 577778-58-6
- Formule: C13H8N6
- Masse moléculaire:248.24
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureté et documentation
-
Help & FAQs
-
HY-14874
Topiroxostat
-
HY-14268
Febuxostat
-
HY-B0219
Allopurinol
-
HY-14268R
Febuxostat (Standard)
-
HY-B0219R
Allopurinol (Standard)
-
HY-N0776
Isorhamnetin
-
HY-19657
Oxypurinol
-
HY-12136
Purpurogallin
-
HY-N5011
5,7-Dimethoxyflavone
-
HY-B0263
Thiabendazole
-
HY-N8600
7,8,3′,4′-Tetrahydroxyflavone
-
HY-N9330
Broussoflavonol F
Product Information
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 577778-58-6
-
Masse moléculaire 248.24
-
Formule C13H8N6
-
SMILES
N#CC1=NC=CC(C2=NNC(C3=CC=NC=C3)=N2)=C1
-
Synonyms
FYX-051 (Standard)
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Sato T, et al. Discovery of 3-(2-cyano-4-pyridyl)-5-(4-pyridyl)-1,2,4-triazole, FYX-051 - a xanthine oxidoreductase inhibitor for the treatment of hyperuricemia [corrected]. Bioorg Med Chem Lett. 2009 Nov 1;19(21):6225-9. [Content Brief]
[2]. Matsumoto K, et al. FYX-051: a novel and potent hybrid-type inhibitor of xanthine oxidoreductase. J Pharmacol Exp Ther. 2011 Jan;336(1):95-103. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Topiroxostat (Standard) Related Classifications
HY-14874R Related Classifications
Powered by Bioz